FDA
-
-
-
-
-
-
-
KemPharm (KMPH) Announces Arimoclomol Research Featured in Two Poster Presentations
-
-
-
-
-
-
-
KemPharm Issues Letter to Shareholders
-
-
-
-
-
-
-
KemPharm (KMPH) Announces Appointment of Christopher Posner as New Independent Director
-
-
-
-
-
-
-
KemPharm Supports Niemann-Pick Awareness Month During October and Global Niemann-Pick Awareness Day on October 19th
-
-
-
-
-
-
-
KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
-
-
-
-
-
-
KemPharm (KMPH) Submits IND of Phase 2 Trial of KP1077 in Idiopathic Hypersomnia
-
-
-
-
-
-
-
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
-
251,230 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All